A carregar...
Efficacy and safety of vilazodone 20 and 40 mg in major depressive disorder: a randomized, double-blind, placebo-controlled trial
Vilazodone is a selective serotonin reuptake inhibitor and 5-HT(1A) partial agonist approved for major depressive disorder (MDD) treatment in adults. This was a 10-week, multicenter, double-blind, placebo-controlled and active-controlled, fixed-dose trial (NCT01473381). Adult patients with MDD (Diag...
Na minha lista:
| Publicado no: | Int Clin Psychopharmacol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Lippincott Williams And Wilkins
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4314105/ https://ncbi.nlm.nih.gov/pubmed/25500685 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/YIC.0000000000000057 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|